foxo4-dri senolytic human trial 2024 foxo4 dri peptide improves spermatogenesis in aged mice through reducing senescence-associated secretory phenotype secretion from Leydig cells FOXO4-DRI: Status, Cancer – Anthony Campbell, PharmD, BCSCP 3ml/10ml:10 x 10ml (100ml) klow peptide
Pay in 4 interest-free payments of $6.14 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 10 - Sep 15